XML 17 R7.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
3 Months Ended
Mar. 26, 2022
Mar. 27, 2021
Cash flows from operating activities:    
Net loss $ (1,372,664) $ (4,185,723)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 267,590 205,023
Accretion of premium or discount on marketable debt securities 128 1,534
Stock-based compensation 656,073 2,610,166
Loss on disposal of property and plant 202,671 14,950
Gain on investments (4,700,000)
Income taxes 35,836 32,070
Foreign currency gains (16,351) (68,351)
Change in allowance for bad debt (26,281) 95,931
Write-off of excess inventory 588,175 408,939
Other non-cash items 453,262 397,211
Changes in assets and liabilities:    
Accounts receivable 5,777,308 1,258,770
Contract assets (252,809) 2,406,334
Inventory (1,156,461) (1,398,350)
Prepaid expenses and other current assets (314,361) (773,067)
Accounts payable and accrued expenses (107,657) (966,202)
Billings in excess of revenue earned (2,317,122) (284,515)
Net cash used in operating activities (2,282,663) (245,280)
Cash flows from investing activities:    
Capital expenditures (524,368) (346,450)
Purchases of marketable debt securities (3,000,030)
Proceeds from sale of marketable debt securities 1,000,000 200,000
Net cash used in investing activities (2,524,398) (146,450)
Cash flows from financing activities:    
Sale of treasury stock, net of costs 15,520,084
Settlements of restricted stock for tax withholding obligations (95,613) (32,705)
Net cash (used in) provided by financing activities (95,613) 15,487,379
Effect of exchange rate changes on cash (17,765) (5,207)
Net (decrease) increase in cash and cash equivalents (4,920,439) 15,090,442
Cash and cash equivalents:    
Beginning of period 26,787,931 17,112,869
End of period $ 21,867,492 $ 32,203,311